Plus Therapeutics presents ReSPECT-LM phase 1 trial data for breast cancer patients with leptomeningeal metastases: Austin, Texas Friday, December 20, 2024, 18:00 Hrs [IST] Plus T ...

Plus Therapeutics (PSTV) presented data updating the progress of its ReSPECT-LM Phase 1 clinical trial of Rhenium Obisbemeda in leptomeningeal disease with a specific focus on breast cancer patients.

Detailed price information for Bell Copper Corp (BCUFF) from The Globe and Mail including charting and trades.

Heilongjiang Provincial Key Laboratory of CO2 Resource Utilization and Energy Catalytic Materials, School of Material Science and Chemical Engineering, Harbin University of Science and Technology, ...

This MSA secures a reliable supply of cGMP Re-186, the radioisotope used in Plus Therapeutics’ lead radiotherapeutic candidate Rhenium (186 Re) Obisbemeda. “This continuing agreement with ...

German and Korean entities are already exploring lithium deposits in East Kazakhstan, with plans to produce nickel-based heat-resistant alloys for jet engines using materials like rhenium and cobalt.

Obisbemeda shows a favorable response rate and median overall survival in leptomeningeal metastases (LM) patients Achieves up to 8x absorbed radiation dose to the CNS subarachnoid space vs. standard ...